➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Mallinckrodt
Johnson and Johnson
Express Scripts
Colorcon

Last Updated: July 4, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR INSULIN ZINC SUSP PROMPT PURIFIED PORK

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Insulin Zinc Susp Prompt Purified Pork

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00467246 Sub-Cutaneous Insulin in Hyperglycaemic Emergencies Withdrawn The Royal Bournemouth Hospital N/A 1969-12-31 Hyperglycaemic emergencies are associated with significant mortality (mortality in Diabetic Ketoacidosis 0.65 - 3.3% and in HyperOsmolar Non-Ketotic Coma 12 -17%). To reduce morbidity and mortality, prompt intervention and coma and close monitoring are essential. The study is designed to investigate whether a simple intervention with a long acting insulin can improve resolution of acidosis and hyperglycaemia, prevent recurrence of ketoacidosis and shorten hospital stay.
NCT00657280 Study of the Effect of Sitagliptin on Glucose (Sugar) Metabolism in Patients With Heart Failure Completed Merck Sharp & Dohme Corp. Phase 0 2008-04-01 This study will investigate the effects of sitagliptin, a medicine commonly used to treat type 2 diabetes, on the utilization of glucose by the heart in patients with heart failure which is not due to heart attacks. We hope to determine whether improving the heart's ability to use glucose in the blood may help improve the function of the heart as well. If so, this may suggest that even people who do not have frank diabetes but who do have heart failure may benefit from using this medication. This study will also investigate the effect of sitagliptin on the body's use of sugar, and of the effect of sitagliptin on blood flow to the heart.
NCT00657280 Study of the Effect of Sitagliptin on Glucose (Sugar) Metabolism in Patients With Heart Failure Completed Stanford University Phase 0 2008-04-01 This study will investigate the effects of sitagliptin, a medicine commonly used to treat type 2 diabetes, on the utilization of glucose by the heart in patients with heart failure which is not due to heart attacks. We hope to determine whether improving the heart's ability to use glucose in the blood may help improve the function of the heart as well. If so, this may suggest that even people who do not have frank diabetes but who do have heart failure may benefit from using this medication. This study will also investigate the effect of sitagliptin on the body's use of sugar, and of the effect of sitagliptin on blood flow to the heart.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Insulin Zinc Susp Prompt Purified Pork

Condition Name

Condition Name for Insulin Zinc Susp Prompt Purified Pork
Intervention Trials
Insulin Resistance 2
Heart Failure, Congestive 1
Type 2 Diabetes 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Insulin Zinc Susp Prompt Purified Pork
Intervention Trials
Insulin Resistance 2
Diabetes Mellitus 2
Hyperinsulinism 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Insulin Zinc Susp Prompt Purified Pork

Trials by Country

Trials by Country for Insulin Zinc Susp Prompt Purified Pork
Location Trials
United States 4
Israel 1
Italy 1
United Kingdom 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Insulin Zinc Susp Prompt Purified Pork
Location Trials
North Carolina 1
District of Columbia 1
New York 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Insulin Zinc Susp Prompt Purified Pork

Clinical Trial Phase

Clinical Trial Phase for Insulin Zinc Susp Prompt Purified Pork
Clinical Trial Phase Trials
Phase 4 2
Phase 3 1
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Insulin Zinc Susp Prompt Purified Pork
Clinical Trial Phase Trials
Unknown status 3
Completed 2
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Insulin Zinc Susp Prompt Purified Pork

Sponsor Name

Sponsor Name for Insulin Zinc Susp Prompt Purified Pork
Sponsor Trials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1
National Institute for Health Research, United Kingdom 1
George Washington University 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Insulin Zinc Susp Prompt Purified Pork
Sponsor Trials
Other 10
Industry 3
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Moodys
Mallinckrodt
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.